This is consistent with the severe upregulation of IGF2BP1 in various malignancies (Table 2) and correlates well with IGF2BP1 de novo synthesis observed in colorectal carcinomas [51, 52]. This evidence concerns the gene IGF2BP1 and colorectal carcinoma.